Skip to main content
. Author manuscript; available in PMC: 2019 Feb 15.
Published in final edited form as: Clin Cancer Res. 2017 Dec 12;24(4):896–905. doi: 10.1158/1078-0432.CCR-17-2664

Figure 3:

Figure 3:

RFVs for PD-L1+ exosomes in plasma of patients with HNSCC stratified by disease activity and stage to create four patient groups: AD-UICC I/II, AD-UICC III/IV, NED-UICC I/II and NED-UICC III/IV. AD patients with high UICC stage had significantly increased RFVs for PD-L1+ exosomes in plasma compared to AD with low UICC stage or NED with low UICC stage.

HHS Vulnerability Disclosure